UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000042142 |
|---|---|
| Receipt number | R000047872 |
| Scientific Title | cohort survey of healthcare workers with COVID-19 infection |
| Date of disclosure of the study information | 2020/10/17 |
| Last modified on | 2020/11/06 09:21:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
cohort survey of healthcare workers with COVID-19 infection
Acronym
cohort survey of healthcare workers with COVID-19 infection
Scientific Title
cohort survey of healthcare workers with COVID-19 infection
Scientific Title:Acronym
cohort survey of healthcare workers with COVID-19 infection
Region
| Japan |
Condition
Condition
COVID-19
Classification by specialty
| Infectious disease | Emergency medicine | Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
to clarify how many healthcare workers are infected with COVID-19
Basic objectives2
Others
Basic objectives -Others
epidemiological study
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
percentage of positive SARS-CoV-2 antibody tests
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
All physicians, nurses, and clinical engineers working in the ICU, Chiba university hospital.
Key exclusion criteria
Those who did not consent to participate in the trial.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Taka-aki |
| Middle name | |
| Last name | Nakada |
Organization
Chiba University Graduate School of Medicine
Division name
Department of Emergency and Critical Care Medicine
Zip code
260-8677
Address
1-8-1, Inohana, Chuo-ku, Chiba
TEL
043-226-2372
taka.nakada@nifty.com
Public contact
Name of contact person
| 1st name | Takeo |
| Middle name | |
| Last name | Kurita |
Organization
Chiba University Graduate School of Medicine
Division name
Department of Emergency and Critical Care Medicine
Zip code
260-8677
Address
1-8-1, Inohana, Chuo-ku, Chiba
TEL
043-226-2372
Homepage URL
tamakichi.kuriken@gmail.com
Sponsor or person
Institute
Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
self-funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Chiba University Graduate School of Medicine
Address
1-8-1, Inohana, Chuo-ku, Chiba
Tel
043-222-7171
inohana-soumu1@chiba-u.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 10 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
103
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2020 | Year | 04 | Month | 23 | Day |
Date of IRB
| 2020 | Year | 05 | Month | 19 | Day |
Anticipated trial start date
| 2020 | Year | 05 | Month | 19 | Day |
Last follow-up date
| 2020 | Year | 05 | Month | 28 | Day |
Date of closure to data entry
| 2020 | Year | 06 | Month | 10 | Day |
Date trial data considered complete
| 2020 | Year | 06 | Month | 11 | Day |
Date analysis concluded
| 2020 | Year | 06 | Month | 15 | Day |
Other
Other related information
epidemiological study.
We've already collected the data.
Management information
Registered date
| 2020 | Year | 10 | Month | 16 | Day |
Last modified on
| 2020 | Year | 11 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047872
